- Home
- SSTI vs COEP Comparison
SSTI vs COEP Comparison
Compare SSTI & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSTI | COEP |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | United States | United States |
| Employees | N/A | 7 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.8M | 72.7M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | SSTI | COEP |
|---|---|---|
| Price | $6.87 | $12.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.80 | N/A |
| AVG Volume (30 Days) | ★ 200.6K | 32.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $34,753,000.00 | N/A |
| Revenue This Year | $11.93 | N/A |
| Revenue Next Year | $9.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 46.25 | N/A |
| 52 Week Low | $5.78 | $6.32 |
| 52 Week High | $18.65 | $21.41 |
Technical Indicators
Market Signals| Indicator | SSTI | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 45.45 |
| Support Level | $6.03 | $11.76 |
| Resistance Level | $7.96 | $13.23 |
| Average True Range (ATR) | 0.58 | 0.86 |
| MACD | -0.01 | 0.11 |
| Stochastic Oscillator | 42.16 | 35.43 |
Price Performance
Historical ComparisonAbout SSTI SoundThinking Inc.
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.